Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-government-funding notice and the prior Revision: v3.4.1 from the history.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the record history to revision 3.4.1 (replacing 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and color-coded change indicators (green for additions and red for deletions); updated the revision from v3.3.4 to v3.4.0 and removed the 'No FEAR Act data' entry.SummaryDifference1%

- Check42 days agoChange DetectedThe page’s Record History shows a new revision entry v3.3.4 added and v3.3.3 removed, which is a metadata update to the version history and does not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedNew: Revision: v3.3.3 added to the record history. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer.SummaryDifference0.2%

- Check85 days agoChange DetectedThe record history now shows Revision: v3.3.2 as the latest version, replacing Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.